Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Johnson & Johnson draws the ire of hospitals and the government over a planned change to how it will provide discounts for some of its 340B-eligible drugs. Pfizer becomes the second drug company to get into the direct-to-consumer market. Those stories and more coming up on today’s episode of the Gist Healthcare podcast.
Hosted on Acast. See acast.com/privacy for more information.